期刊文献+

酸性鞘磷脂酶/神经酰胺通路在疾病发生发展中作用机制的研究进展 被引量:5

Research Progress in Acidic Sphingomyelinase/Ceramide Pathway: Its Role and Mechanism in Development of Related Diseases
原文传递
导出
摘要 酸性鞘磷脂酶/神经酰胺通路可介导细胞凋亡、炎症和自噬等多种细胞活动,与心脑血管疾病、代谢类疾病、肺部和肝部疾病以及神经系统疾病等多种疾病的发生、发展密切相关。酸性鞘磷脂酶现已成为多种疾病的临床生物标记物和潜在的治疗靶点。综述酸性鞘磷脂酶/神经酰胺通路在各种疾病中的生物学功能和作用机制最新研究进展,旨在为相关疾病的治疗提供新思路。 Acidic sphingomyelinase(ASMase)/ceramide(CE) pathway mediates various cellular processes including cell apoptosis, infl ammation and autophagy, and is closely associated with the development of many human diseases, including cardiovascular and cerebrovascular, metabolic, pulmonary, hepatic and neurological disorders. ASMase has been regarded as a promising clinical biomarker and potential therapeutic target for many diseases. The recent progress in investigations on the biological functions and mechanisms of ASMase/CE pathway in these diseases was reviewed, so as to provide new ideas for the treatment of related diseases.
出处 《药学进展》 CAS 2015年第11期838-845,共8页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金面上项目(No.81473231)
关键词 酸性鞘磷脂酶 神经酰胺 细胞凋亡 疾病 acid sphingomyelinase ceramide apoptosis disease
  • 相关文献

参考文献60

  • 1Jenkins R W, Canals D, Hannun Y A. Roles and regulation of secretory and lysosomal acid sphingomyelinase [J]. Cell Signal, 2009, 21 (6): 836- 846.
  • 2Kornhuber J, P,.hein C, M~iller C P. et al. Secretory sphingomyelinase in health and disease[J]. Biol Chem, 2015, 396(6/7): 707-736.
  • 3Sentelle R D. Senkal C E, Jiang W, et al. Ceramide targets auto- phagosomes to mitochondria and induces lethal mitophagy[J]. Nat Chem Biol, 2012, 8(10): 831-838.
  • 4Teichgr~iber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis[J]. Nat Med, 2008, 14(4): 382-391.
  • 5Tabas I, Williams K J, Bor6n J. Subendothelial lipoprotein retention as the initiating process. in atherosclerosis: update and therapeutic implications[J]. Circulation, 2007, 116(16): 1832-1844.
  • 6Devlin C M, Leventhal A R, Kuriakose G. et al. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression[J]. Arterioscler Thromb Vasc Biol, 2008, 28(10): 1723-1730.
  • 7Wong M L, Xie B, Beatini N, et aL Acute systemic inflammation up-regulates secretory sphingomyelinase in VlVO: a possible link between inflammatory cytokines and atherogenesis[J]. Proc Natl Acad Sci USA, 2000, 97(15): 8681-8686.
  • 8Deevska G M. Sunkara M, Morris A J, et al. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet[J]. Biosci Rep, 2012, 32(5): 479-490.
  • 9Li P L, Zhang Y, Yi F. Lipid raft redox signaling platforms in endothelial dysfunction[J]. AntioxidRedox Signal, 2007, 9(9): 1457-1470.
  • 10Li X, Beeker K A, Zhang Y. Ceramide in redox signaling and cardiovascular diseases[J]. Cell Physiol Biochem, 2010, 26(1): 41-48.

二级参考文献26

  • 1张雪梅,李磊,张刚磊,赵士魁.3,4-二羟基苯甲醛合成工艺的改进[J].徐州师范大学学报(自然科学版),2006,24(3):51-53. 被引量:8
  • 2Marathe S, Miranda SR, Tabas I. , Hum Mol Genet, 2000, 9(13), 1967.
  • 3Vit JP, Rosselli F. , Oncogene, 2003, 22(54), 8645.
  • 4Glady H. S. , Stefania L. , Andreea M. B. , Journal of Dermatological Science, 2012, 67, 166–172.
  • 5Chang,S. W. , Feddersen, C.O. , Henson, P. M. , J. Clin. Invest. , 1987, 79, 1498–1509.
  • 6G?ggel R, Winoto-Morbach S, Vielhaber G. , Nat Med., 2004, 10, 155-160.
  • 7Petrache I. , Natarajan V. , Zhen L. , Nat Med., 2005, 11, 491-498.
  • 8J. Kornhuber, A. Medlin, S. Bleich , V. Jendross . , J. Neural Transm., 2005, 112, 1583–1590.
  • 9Johannes K. , Martin R. P. , Tripal T. W. , Eur Arch Psychiatry Clin Neurosci, 2009, 259 (2), S199–S204.
  • 10Devlin C. M. , Leventhal A. R. , Kuriakose G. , Arterioscler Thromb Vasc Biol., 2008, 28, 1723-1730.

同被引文献44

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部